Federal Home Loan Mortgage Corp.'s Risk to the Government Assigned 'AA-' Rating Feb 01

  • ID: 1710101
  • February 2001
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's CreditWire) Feb. 27, 2001Standard & Poor's today assigned a double-'A'-minus risk to the government credit rating of Federal Home Loan Mortgage Corp. (Freddie Mac). The risk to the government credit rating refers to the inherent default risk of a federally related entity operating under its authorizing legislation, but without assuming an infusion of cash by the federal government. In evaluating the risk to the government, the underlying or inherent credit quality of the entity is reviewed. In determining Freddie Mac's risk-to-the-government credit rating, Standard & Poor's has incorporated the evaluation of such factors as business fundamentals, including Freddie Mac's competitive position, evaluation of management and its strategies, and examination of relevant financial measures. The underlying...

Companies mentioned in this report are:
- Freddie Mac

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Freddie Mac

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.